Received Aug 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
No symptomatic events were reported; PROQUAD dose given to a 16 year old female; This spontaneous report was received from a Physician Assistant (reported as medical assistant) and refers to a 16-years-old female patient. The patient's medical history, concurrent conditions, concomitant therapies, past drug reactions and allergies were not reported. On 17-JUL-2025, the 16-years-old patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), Injection, administered for prophylaxis (dose, route of administration, anatomical site of injection, lot number and expiration date were not reported), which was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot number and expiration date were not reported) (Product administered to patient of inappropriate age). No symptomatic events or additional adverse events were reported for the patient (No adverse event). No additional information was provided.
Sterile diluent